Normal tissue complication probability models for severe acute radiological lung injury after radiotherapy for lung cancer

The models and dose levels derived can be used in differential diagnosis of tumor recurrence from RRLI in patients treated with RT. Cross validation is needed to prove prediction performance of the model outside the dataset from which it was derived.